Cargando…
Congenital disorder of glycosylation – one size does not fit all: a parent’s perspective
This article is written by the parent of a child living with PMM2-congenital disorder of glycosylation (abbreviated to PMM2-CDG). It provides a parental perspective of the journey taken from diagnosis to present day and details the effect of off-label treatment with epalrestat.
Autor principal: | Feinberg, Konstantin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032444/ https://www.ncbi.nlm.nih.gov/pubmed/37180418 http://dx.doi.org/10.1177/26330040221118099 |
Ejemplares similares
-
Mannose treatment improves immune deficiency in mannose phosphate
isomerase–congenital disorder of glycosylation: case report and review of
literature
por: De Graef, Diederik, et al.
Publicado: (2022) -
Novel insights into the phenotype and long-term D-gal treatment in
PGM1-CDG: a case series
por: Radenkovic, Silvia, et al.
Publicado: (2023) -
Left-sided valvular heart disease and retinopathy in a 38-year-old
woman with attenuated mucopolysaccharidosis: a case report
por: Asumda, Faizal Z., et al.
Publicado: (2023) -
One size does not fit all
por: Tautz, Diethard
Publicado: (2014) -
One-size MAP does not fit all
por: Senussi, Mourad H
Publicado: (2015)